Phathom Pharmaceuticals Inc (PHAT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Phathom Pharmaceuticals Inc-Aktie (PHAT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	16.32% 57.58	49.50	39.50	28.52	29.66
Cost Of Revenue	23.55% 7.648	6.19	5.038	3.724	3.815
Gross Profit	15.29% 49.94	43.31	34.47	24.80	25.85
Operating Expenses	4.64% 55.86	58.59	94.39	103.66	85.27
Benefits Costs and Expenses	78.73	-	-	122.83	104.11
Costs And Expenses	21.55% 78.73	64.78	99.43	122.83	104.11
Operating Income/Loss	61.18% -5.928	-15.27	-59.92	-78.86	-59.42
Nonoperating Income/Loss	3.52% -15.22	-14.70	-15.89	-15.45	-15.03
Income/Loss From Continuing Operations Before Tax	142.72% -21.15	49.50	-75.81	-94.32	-74.45
Income/Loss From Continuing Operations After Tax	29.44% -21.15	-29.97	-75.81	-94.32	-74.45
Net Income/Loss	29.44% -21.15	-29.97	-75.81	-94.32	-74.45
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.59% 0.3029	73.40	72.47	71.97	2.6327
Diluted Average Shares	99.59% 0.3029	73.40	72.47	71.97	2.6327
Basic Earnings Per Share	34.15% -0.27	-0.41	-1.05	-1.31	-1.00
Diluted Earnings Per Share	34.15% -0.27	-0.41	-1.05	-1.31	-1.00
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%